📖

BID — BH3 Interacting Domain Death Agonist

wiki page Created: 2026-04-02 13:40:08 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-bid
Related Entities
BID
Metadata
sluggenes-bid
entity_typegene
kg_node_idBID
Linked Artifacts (110)
mentions🧪Bacterial Enzyme-Mediated Dopamine Precursor Synthesis90%
related🧪Bacterial Enzyme-Mediated Dopamine Precursor Synthesis90%
mentions🔬Is disrupted sleep a cause or consequence of neurodegenerati75%
mentions🔬Is disrupted sleep a cause or consequence of neurodegenerati75%
mentions🧫Cholinergic System Dysfunction in DLB — Mechanisms and Thera70%
related🧫Cytochrome Therapeutics70%
related🧫ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De70%
related🧫Animal Model Comparison for Neurodegenerative Disease Therap70%
related🧫Endocannabinoid System Dysfunction Validation in Parkinson&#70%
related🧫Glymphatic-Circadian Axis Enhancement Therapy for Parkinson&70%
related🧫Gut Microbiome-Derived Metabolites in Alpha-Synuclein Propag70%
related🧫Neural Oscillation Dysfunction Validation in Parkinson'70%
related🧫Oligodendrocyte-Myelin Dysfunction Validation in Parkinson&#70%
related🧫Proteasome-Ubiquitin System Dysfunction Validation in Parkin70%
related🧫Protein Aggregation Kinetic Validation Results70%
related🧫Purinergic Signaling Dysfunction Validation in Parkinson70%
related🧫Regulated Necrosis Validation Study in Parkinson's Dise70%
related🧫Stress Granule Dysfunction Validation in Parkinson's Di70%
related🧫Experiment Validation: In vitro ThT Assay70%
related🧫Macroautophagy Dysfunction in PD - Experiment Design70%
related🧫Cytochrome Therapeutics70%
related🧫ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De70%
related🧫Animal Model Comparison for Neurodegenerative Disease Therap70%
related🧫Endocannabinoid System Dysfunction Validation in Parkinson&#70%
related🧫Glymphatic-Circadian Axis Enhancement Therapy for Parkinson&70%
related🧫Gut Microbiome-Derived Metabolites in Alpha-Synuclein Propag70%
related🧫Neural Oscillation Dysfunction Validation in Parkinson'70%
related🧫Oligodendrocyte-Myelin Dysfunction Validation in Parkinson&#70%
related🧫Proteasome-Ubiquitin System Dysfunction Validation in Parkin70%
related🧫Protein Aggregation Kinetic Validation Results70%
related🧫Purinergic Signaling Dysfunction Validation in Parkinson70%
related🧫Regulated Necrosis Validation Study in Parkinson's Dise70%
related🧫Stress Granule Dysfunction Validation in Parkinson's Di70%
related🧫Experiment Validation: In vitro ThT Assay70%
related🧫Macroautophagy Dysfunction in PD - Experiment Design70%
related🧫Cholinergic System Dysfunction in DLB — Mechanisms and Thera63%
see_also📖Apoptosis in Neurodegeneration60%
see_also📖caspases60%
see_also📖SMAC Gene60%
see_also📖Apoptosis Pathway in Neurodegeneration60%
see_also📖BAK1 Gene60%
see_also📖PPP1CB Gene60%
see_also📖Amyloid-Related Imaging Abnormalities (ARIA)60%
see_also📖Oxidative Stress in Corticobasal Syndrome60%
see_also📖Oxidative Stress in Neurodegeneration60%
see_also📖Oxidative Stress in Neurodegeneration60%
see_also📖Oxidative Stress Pathway60%
see_also📖SCRIB Gene60%
see_also📖ATXN2 Gene60%
see_also📖CNTN4 — Contactin 460%
see_also📖TBC1D24 Gene60%
see_also📖Packard Center for ALS Research60%
see_also📖CCNF Protein (Cyclin F)60%
see_also📖Survival Motor Neuron (SMN)60%
see_also📖Heterogeneous Nuclear Ribonucleoprotein A2/B1 (HNRNPA2B1)60%
see_also📖HNRNPA2B1 - Heterogeneous Nuclear Ribonucleoprotein A2/B160%
see_also📖PLIN4 Gene60%
see_also📖TIA1 - TIA1 Cytotoxic Granule Associated RNA Binding Protein60%
see_also📖HNRNPA2B1 Protein60%
see_also📖proteins-hnrnpa2b1-protein60%
see_also📖TIA1 Protein60%
see_also📖proteins-tia1-protein60%
see_also📖ATM Gene60%
see_also📖ATR Gene60%
see_also📖MTCH2 — Mitochondrial Carrier Homolog 260%
see_also📖ABCG2 (BCRP) - ATP Binding Cassette Subfamily G Member 260%
see_also📖AKT1 Gene60%
see_also📖PANK2 — Pantothenate Kinase 260%
see_also📖PLA2G6 — Phospholipase A2 Group VI60%
see_also📖Alzheimer Indonesia60%
mentions🧫Antiviral Therapy Trial for Parkinson's Disease50%
mentions🧫cGAS-STING Pathway Validation Study in Parkinson's Dise50%
mentions🧫Cholinergic System Dysfunction in DLB — Mechanisms and Thera50%
mentions🧫Cytochrome Therapeutics50%
mentions🧫Viral Infections and Alzheimer's Disease — causal mecha50%
mentions🧪Purinergic Signaling Polarization Control50%
mentions🧪Pericyte Contractility Reset via Selective PDGFR-β Agonism50%
mentions🧪Mechanosensitive Ion Channel Reprogramming50%
mentions🧪Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna50%
mentions🧪Blood-Brain Barrier SPM Shuttle System50%
mentions🧪Senescent Microglia Resolution via Maresins-Senolytics Combi50%
mentions🧪Purinergic P2Y12 Inverse Agonist Therapy50%
mentions🧪Dual-Domain Antibodies with Engineered Fc-FcRn Affinity Modu50%
mentions🧪Low Complexity Domain Cross-Linking Inhibition50%
mentions🧪Glycine-Rich Domain Competitive Inhibition50%
mentions🧪Interfacial Lipid Mimetics to Disrupt Domain Interaction50%
mentions🧪Competitive APOE4 Domain Stabilization Peptides50%
related🔬What are the mechanisms underlying tdp-43 phase separation t50%
related🔬What are the mechanisms underlying blood-brain barrier trans50%
related🔬What are the mechanisms underlying apoe4 structural biology 50%
related🔬What are the mechanisms underlying what are the mechanisms b50%
related🔬What are the mechanisms underlying synaptic pruning by micro50%
related🔬What are the mechanisms underlying tdp-43 phase separation t50%
related🔬What are the mechanisms underlying blood-brain barrier trans50%
related🔬What are the mechanisms underlying apoe4 structural biology 50%
related🔬What are the mechanisms underlying what are the mechanisms b50%
related🔬What are the mechanisms underlying synaptic pruning by micro50%
related🔬Analyze circuit-level changes in neurodegeneration using All50%
related🔬Is disrupted sleep a cause or consequence of neurodegenerati50%
related🔬Is disrupted sleep a cause or consequence of neurodegenerati50%
related🔬APOE4 differs from APOE3 by C112R causing domain interaction50%
mentions🔬APOE4 differs from APOE3 by C112R causing domain interaction40%
mentions🔬Analyze circuit-level changes in neurodegeneration using All40%
related🧪Dual-Domain Antibodies with Engineered Fc-FcRn Affinity Modu40%
related🧪Low Complexity Domain Cross-Linking Inhibition40%
related🧪Glycine-Rich Domain Competitive Inhibition40%
related🧪Interfacial Lipid Mimetics to Disrupt Domain Interaction40%
related🧪Competitive APOE4 Domain Stabilization Peptides40%
related🧪Purinergic P2Y12 Inverse Agonist Therapy40%
related🧪Axonal RNA Transport Reconstitution40%